Consensus on molecular imaging and theranostics in neuroendocrine neoplasms


Ambrosini V., Kunikowska J., Baudin E., Bodei L., Bouvier C., Capdevila J., ...More

EUROPEAN JOURNAL OF CANCER, vol.146, pp.56-73, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 146
  • Publication Date: 2021
  • Doi Number: 10.1016/j.ejca.2021.01.008
  • Title of Journal : EUROPEAN JOURNAL OF CANCER
  • Page Numbers: pp.56-73

Abstract

Nuclear medicine plays an increasingly important role in the management neuroendocrine neoplasms (NEN). Somatostatin analogue (SSA)-based positron emission tomography/computed tomography (PET/CT) and peptide receptor radionuclide therapy (PRRT) have been used in clinical trials and approved by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA).